Certara CoAuthor Alternatives for Regulated Writing Teams

This guide is for teams evaluating alternatives to Certara CoAuthor, or deciding whether CoAuthor should stay while another product closes a defined gap. “Certara alternatives” is too broad for a useful procurement decision. Name the CoAuthor workflow, document family, repository, template set, and export requirement first. A team drafting a CSR in Word has a different problem from a team managing a complete submission lifecycle.

Method and disclosure: Assyro publishes this guide and Assyro is our first editorial recommendation to evaluate for connected preparation, review, and validation. Product descriptions were checked against official vendor materials on September 14, 2026. This is documentary research, not an independent benchmark, validation study, security audit, or migration certification. Vendor claims about speed, quality, compliance, or productivity are not treated as independent proof.

Identify the CoAuthor workflow you are replacing

Certara’s CoAuthor page describes Word integration, configurable eCTD templates, structured content, source-restricted generation, styling, references, metadata, collaboration, version control, and Veeva integration. These descriptions do not establish support for a particular template, Veeva tenant, or historical record in the proposed configuration.

Its CoAuthor fact sheet adds a concrete Word distinction: CoAuthor operates alongside existing macros and toolbars. It describes AI content blocks labeled with their prompts, source referencing, and comments and tracked changes identifying source additions. This older fact sheet supports specific questions for a current demonstration; it does not certify your macro set or Word version.

Source: Certara's CoAuthor product page, checked September 14, 2026. View original image. The vendor demo image has a February 2025 upload path; its software release and capture date are unspecified. The prompt is blurred in the original image. This shows the authoring surface, not a tested source-selection or accuracy result.

Write the requirement as a sentence:

“

We need to replace Certara CoAuthor for [document family and section], using [source package], in [Word/repository workflow], while retaining [template, metadata, references, review decisions, version history, and downstream handoff].

If the team cannot fill in the brackets, do requirements discovery before comparing vendors. Ask whether the current work includes medical-writing services, source preparation, regulatory strategy, publishing, or Veeva administration. A software license does not automatically include those responsibilities.

Keep GlobalSubmit separate. Certara lists it as a publishing product alongside CoAuthor. A GlobalSubmit publishing result does not prove a CoAuthor editing feature, and replacing CoAuthor does not by itself replace the publisher.

Candidate map at product and workflow level

This is a selective comparison set, not a market ranking. Product-level scope remains configuration-specific; use the selection rule below for mandatory requirements. Missing public documentation is a reason to request proof, not proof that the vendor cannot provide it.

Selection rule for every candidate: a mandatory requirement without sufficient evidence remains unresolved, and the candidate is ineligible for that replacement scope until it is demonstrated. A confirmed unavailable requirement excludes it from that scope. Missing public documentation alone does not prove that a capability is unavailable.

Assyro: first evaluation with a capability gate

Assyro is our default editorial starting recommendation when the buyer needs connected document preparation, review, and validation handoffs. Its public eCTD authoring page and validation page describe relevant workflows, with the validation page oriented to eCTD v4.0. Confirm the current deployed configuration, supported document types, required source systems, output, and existing submission history before treating Assyro as a CoAuthor replacement.

Run a small, permitted document exercise with the exact document type and source package. Have an author draft one controlled section, inspect the evidence behind key statements, have a reviewer accept and reject changes, and produce the defined downstream output. Include the Veeva or repository handoff only if it is mandatory for the intended configuration. This exercise establishes fit for the tested workflow; it does not establish every CoAuthor capability.

Mandatory gate: if the buyer requires a native Word add-in, a specific Veeva integration, a named eCTD template set, a particular document type, retained historical revisions, or a specific export, Assyro is unresolved and ineligible for selection until that requirement is explicitly demonstrated in the current configuration. Assyro-first placement is an editorial recommendation and does not waive a must-have.

Yseop Copilot: the closest workflow question is Word plus controlled reuse

Yseop Copilot describes drafting directly in Word and Veeva, with section locks, reuse, and validation against source changes. That combination makes it relevant when CoAuthor users want to keep their writing environment but change how reusable passages and updates are managed.

Start with one reusable paragraph that is approved and one that needs scientific review. Ask the offered configuration to preserve the approved text while directing the writer to review the other passage. Then inspect the output inside the buyer’s Word environment. Does the paragraph remain editable under the intended policy? Can the reviewer recover the source and outstanding question? Does an existing template tool still work? Word integration is documented; compatibility with a particular CoAuthor-derived template or macro is not established by that statement.

Choose a Yseop evaluation when controlled reuse and source changes are the reason for considering a switch. Keep CoAuthor if its structured content and Word controls already meet the need and the proposed improvement disappears once template conversion and reviewer reconciliation are included. Confirm the offered document scope, Veeva connection, and support responsibilities before pricing the move. A clinical writing pilot does not establish every CMC or safety workflow in a vendor catalog.

Peer AI Author: consider a shared editing environment if native Word is optional

Peer’s authoring description, dated July 14, 2026, describes in-document collaboration, source-mapped drafts, contextual comments, and version comparison and rollback. It describes a purpose-built editing environment. Similarity to collaborating in Word is not a claim that the work happens inside Microsoft Word.

That distinction can change the shortlist. A team willing to review in a shared environment can evaluate how reviewers follow a source into a draft and settle comments there. A team whose mandatory workflow depends on a Word toolbar must first establish whether its requirement can be met. Do not substitute a browser editing demonstration for that answer.

Consider Peer Author when keeping the team together during source review matters more than retaining a particular editor. Stay with CoAuthor if moving review would break required native Word behavior or leave historical decisions inaccessible. Require the receiving document owner to inspect both the output and any source history that stays on the platform. Peer’s Orchestrate and Anticipate capabilities address program coordination and predicted regulator questions; they are separate scope questions. Neither should compensate for an unresolved Author editing requirement, even when offered within one platform.

The Peer AI alternatives comparison expands the difference between authoring and the broader coordination functions a replacement may leave behind.

Weave Submission Builder: evaluate an explicit DOCX and repository handoff

Weave Bio Submission Builder describes a shared review workspace, source verification, version history and restoration, DOCX export, and Veeva import/export. This gives the buyer a concrete transfer path to examine when the required deliverable is a reviewed document rather than an authoring tool embedded in Word.

Distinguish two possible operating models. In one, reviewers finish inside the platform and receive a final document. In the other, the exported file remains an active Word review copy that must carry open comments, proposed edits, fields, and metadata. The second imposes a different requirement. A downloadable DOCX does not prove that those objects remain usable.

Shortlist Submission Builder when its shared review and document handoff match the intended operating model. Stay with CoAuthor if an external reviewer must continue native Word work and the exported file loses the required objects. Run the same handoff packet below, including re-opening and editing the output. Ask which source references remain live only inside Weave and which travel to the repository. Price the retained archive and review access as part of the workflow; do not assume a file export replaces them.

Narrativa Clinical Atlas: a narrower option for the clinical drafting gap

Narrativa Clinical Atlas describes CSR generation from tables, listings, and figures, and protocol generation from a study synopsis. That input-specific scope is useful when the CoAuthor replacement question concerns one clinical document family rather than the team’s whole writing environment.

Give the vendor the actual input form the writers receive. A formatted TLF package and a study synopsis are different starting points; a successful demonstration with one does not establish the other. Require the generated section to retain the requested labels, source relationship, and review questions when placed in the controlled template. Native Word editing, macro compatibility, and the exact export remain separate proof points.

Evaluate Clinical Atlas for a bounded clinical drafting bottleneck. Keep CoAuthor or use a complement if the broader template and Word review process already works. Define who transfers the generated content, checks it, and owns the source record. Narrativa also names other products, including Narrative Pathway and TLF Voyager; their capabilities should not silently become Clinical Atlas requirements or inclusions. Obtain the exact product and input/output scope before comparing the proposed service and implementation effort with CoAuthor.

Preserve what CoAuthor makes valuable

Start with the artifacts rather than the vendor name. Export a representative CoAuthor package and inventory the Word document, template identifier, section structure, styles, metadata, hyperlinks, citations, reusable content, source references, comments, tracked changes, reviewer decisions, version history, roles, and Veeva objects. Ask Certara which of those are exportable, machine-readable, or dependent on the CoAuthor environment. If a record is available only through the application, plan how it will remain accessible during and after a transition.

Separate source controls from generated prose. CoAuthor’s page describes source-restricted generation and traceability, but the buyer still needs to test the local source contract. Identify the approved source set for a claim, the source version, the person who owns it, and the response when two sources conflict. The alternative should show the source behind a key sentence and preserve the reviewer’s disposition. A citation pasted into a Word file is not necessarily an auditable link to the exact source version.

Templates are operational rules. Record section order, required headings, style definitions, tables, footnotes, reference format, page behavior, metadata, hyperlinks, and document naming. Ask an alternative to produce the same section from the same controlled template. Compare the result in Word and after downstream import. A system that creates a readable file but loses metadata, hyperlinks, tracked changes, or required styles has created a migration task rather than a drop-in replacement.

Veeva integration needs its own acceptance test. Name the Veeva product and object involved, the direction of transfer, the required metadata, the user identity and permissions, and the expected behavior when a document is revised. Veeva RIM includes Registrations, Submissions, Submissions Publishing, and Submissions Archive; do not reduce the handoff to “Veeva support.” CoAuthor’s public integration statement is a starting point for questions, not evidence that every Veeva application or tenant configuration is supported.

Use the source-traceability checklist to challenge whether governed reusable content still supports the new document’s particular claim.

Assyro vs Certara CoAuthor: prove editing, review, and export separately

CoAuthor has explicit vendor evidence for operating inside Word; equivalent Assyro native Word functionality is unverified here. Neither product has been tested for this article. If native Word editing is mandatory, CoAuthor’s documented integration earns a demonstration; Assyro remains ineligible for that requirement pending proof. Assyro’s connected preparation and validation workflow may justify an evaluation when that is the actual gap, but cannot settle a Word feature question.

Agree on three separate requirements before the demonstration:

Use the following synthetic handoff packet, not a full CSR. Its purpose is to expose lost editing objects, not measure clinical writing quality. Record Word edition, operating system, add-ins, candidate configuration, and whether the file must return to the authoring platform after external review.

The packet contains approved source D08 design note v1, stating: “Study D08 has two cohorts, A and B.” Template T7 requires a heading with style StudyHeading, a two-row cohort table with an automatically numbered caption initially showing Table 1, and a paragraph containing a field-based cross-reference to that table. Set document property StudyID to D08. Include an open comment on the cohort sentence asking the writer to identify its source. Preserve the baseline before any change.

Run this sequence with both vendors:

1. Prepare and identify. Populate the heading, cohort sentence and table from D08 v1. Show the source identifier behind the sentence. If a native Word add-in is required, show the offered tool operating inside the agreed Word environment and run a required existing template command. A browser editor or a Word file opened after export is insufficient evidence of an add-in.
2. Edit the structure. Insert another captioned table before the cohort table, then update references using the supported workflow. The cohort table is now Table 2; the cross-reference must still target it and display the new number. Microsoft documents cross-references as fields; inspect the field and target, not just the displayed number. Replacing the reference with visually correct plain text fails this requirement.
3. Review a proposed change. Deliberately propose changing “two cohorts” to “three cohorts” using the agreed review mechanism. The reviewer rejects it against D08 v1, answers the source comment, and leaves a separate formatting comment open. Preserve the rejection rationale in the agreed review record; do not assume a rejected revision remains visible in the final file.
4. Hand back and reopen. Give the output and review record to a second owner. They must find two cohorts, the Table 2 reference, StudyHeading, StudyID=D08, the open formatting comment at the intended passage, and the source/rejection record. Have them edit the file and, if required, return it to the platform. Inspect what survives that return separately from the first export.

Stay with CoAuthor if this configured workflow passes and an alternative needs manual reconstruction of mandatory objects. Consider Assyro when its required steps pass and the benefit is the connected preparation handoff. Use a complement if CoAuthor should retain Word authoring while another evidenced workflow handles the gap. An unsupported statement that Assyro “works in Word” must be removed from the decision record and the requirement reopened, even if the displayed document looks correct.

Build a decision record that survives procurement

Turn the exercise into a requirement register instead of a collection of demo notes. Give each row an owner, criticality, source, test method, and pass condition. For example: “The external reviewer can update the cohort-table cross-reference in the handed-back file without rebuilding the field.” Record the actual output and who inspected it. Separate native editing, output fidelity and the return path so that a pass on one cannot hide a failure on another.

Use three evidence statuses: documented, demonstrated, and unresolved. Documented means the vendor’s current official material explicitly describes the capability. Demonstrated means the buyer observed it meet the pass condition with its representative package and recorded the result. Unresolved means the material or test does not answer the requirement. Record a confirmed unavailable capability separately as an exclusion. A mandatory unresolved row cannot pass until its configuration-specific evidence is sufficient; an editing-fidelity requirement needs the actual output. This keeps procurement from turning an adjacent claim into eligibility.

Ask for the buyer’s actual operating boundary in the same meeting as the product demonstration. Who prepares TLFs? Who approves a template change? Who owns source corrections? Who controls Veeva permissions? Who signs the final document? If CoAuthor is part of a broader Certara service or technology arrangement, separate the product’s responsibility from the people and systems around it. A replacement can pass a feature checklist and still fail because the team has not replaced an important human or operational control.

Transfer the tested requirements into the AI writing RFP workbook before treating a feature demonstration as a complete proposal.

Full replacement, complement, or stay

A full replacement of CoAuthor requires evidence for the named authoring workflow, document family, source controls, templates, review, version history, output, and each required integration. If the current CoAuthor deployment includes services, data preparation, template maintenance, or Veeva administration, assign those responsibilities explicitly after the switch. The alternative may be capable while the proposed operating model is incomplete.

A complement can be better when CoAuthor already satisfies controlled Word authoring and the problem is narrower: a separate source-reconciliation step, a validation handoff, a document family outside the configured templates, or a new review queue. Keep CoAuthor as the system of record for the retained workflow and define where the complementary tool starts and ends. Do not create two competing approved copies.

Staying is reasonable when the current CoAuthor package passes the controlled template exercise, the required Veeva handoff works, and the switching trigger is only a general desire for newer AI features. A new tool adds source mapping, template recreation, training, validation, parallel-run, and archive work. Document the gap that justifies that cost.

Migration, ownership, and exit

Request an inventory of CoAuthor assets before signing a replacement contract. Include templates, reusable content, source links, Word styles, metadata mappings, hyperlinks, comments, tracked changes, reviewer decisions, version history, user roles, Veeva identifiers, final files, and archive obligations. Ask for a sample export and inspect it with the people who will own the archive. “We can export Word” does not answer whether the source and decision relationships survive.

Choose a cutover boundary by document or program. Finish an in-review document in CoAuthor when preserving its history is safer; start a new document in the alternative only after its sources, template, and owner are mapped. During overlap, assign one person to resolve edits and identify the approved version. Keep a register of documents that were started, reviewed, approved, or exported in each system.

Budget template recreation, source mapping, integration configuration, permissions, intended-use or validation work, reviewer training, service support, parallel operation, downstream publishing, and archive access. Ask what happens if the contract ends: can the team retrieve approved documents, source references, audit records, templates, and metadata in usable formats? Obtain that answer in writing and test a sample where feasible. Migration compatibility remains unresolved until the relevant artifact and history are demonstrated.

Plan a focused Assyro evaluation

Bring one controlled template, the required Word features, and the exact downstream repository or publishing handoff. Use the D08 packet to agree what must remain editable and what evidence must accompany the file. If native Word integration is mandatory, resolve that eligibility question before a broader Assyro evaluation.

Discuss your Certara CoAuthor workflow with Assyro. Ask which capabilities are available in the current offered configuration, which systems or services remain responsible, and what evidence is still needed before a replacement decision. Keep the pilot bounded to the work you want to improve.

Use Assyro’s regulatory-writing overview to frame the proposed task, with editing, review and export still demonstrated separately.

Reference material

• Certara CoAuthor, official product page; checked September 14, 2026; no displayed revision date.
• CoAuthor fact sheet, two-page vendor PDF at a November 2024 path; no internal revision identifier displayed. Current configuration requires confirmation.
• Assyro eCTD authoring and eCTD validation, official pages; checked September 14, 2026.
• Veeva RIM, official product family page; checked September 14, 2026.
• Yseop Copilot, Peer AI, Weave Bio Submission Builder, and Narrativa regulatory solutions, official pages; checked September 14, 2026.